Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant DisordersOrly R. Klein, Heather J. Symons, Allen Chen et al.|Biology of Blood and Marrow Transplantation|2016Cited by 76
Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic MalignanciesOrly R. Klein, Heather J. Symons, Allen Chen et al.|Biology of Blood and Marrow Transplantation|2016Cited by 73
Hypoxia-Sensitive Epigenetic Regulation of an Antisense-Oriented lncRNA Controls WT1 Expression in Myeloid Leukemia CellsGregory McCarty, David M. Loeb|PLoS ONE|2015Cited by 69
Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen–Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic MalignanciesElad Jacoby, Heather J. Symons, Allen Chen et al.|Biology of Blood and Marrow Transplantation|2015Cited by 46
Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell lineJoseph B. Moore, R.J. Arceci, David M. Loeb et al.|Frontiers in Cell and Developmental Biology|2015Cited by 27